The First Secretary of the Central Committee of the Communist Party of Cuba and President of the Republic, Miguel Díaz-Canel Bermúdez, congratulated Cuban scientists upon learning that Mexico's Federal Committee for Protection from Sanitary Risks (COFEPRIS) authorized the emergency useof Cuban vaccines Soberana and Soberana Plus.
"I receive this excellent news in Moscow. Our Soberana vaccines continue to show their quality and effectiveness. Congratulations to the Cuban scientists and thanks again for the feat. A hug," the head of state wrote on Twitter.
COFEPRIS ruled the authorization of Soberana 02 and Soberana Plus with the distinctive names: recombinant protein of the SARS-COV-2 virus receptor binding domain (RBD), conjugated to tetanus toxoid; and recombinant protein of the SARS-COV-2 virus receptor binding domain (RBD), respectively.
The authorizations issued by this commission are part of the National Health Regulation Strategy, which reviews and provides access to the largest number of health inputs, as long as the quality, safety and efficacy of the product are proven, adds an official note.
The Mexican regulatory entity assured that the Cuban vaccines received a favorable opinion from the National Committee of Science and Technology and Innovation in Health of the National Council of Science and Technology and the New Molecules Committee (CMN in Spanish).
After preparing the opinion of the CMN and submitting the request for authorization for emergency use to COFEPRIS, a staff specialized in vaccines analyzed the dossiers, certifying that the vaccines meet the quality, safety and efficacy requirements necessary for its use, according to the information published on the Mexican Government's website.
As COFEPRIS is a National Regulatory Authority of reference qualified by the Pan American Health Organization (PAHO), its decisions are recognized by several countries of the continent, so the approved vaccines could be used in other nations.
